Revatio
sildenafil citrate
- Strength
- 20 mg/1
- Form
- Tablet, Film Coated
- Class
- Phosphodiesterase 5 Inhibitor
PFIZER LABORATORIES DIV PFIZER INC
Listed by Exelan Pharmaceuticals, Inc.
| Dosage form | Tablet |
|---|---|
| Route | Oral |
| Drug class | Phosphodiesterase 5 Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 76282-643 |
| FDA application | ANDA207178 |
| RxNorm concept | 312950 |
| Package sizes listed | 1 |
| Marketed since | July 2022 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
sildenafil citrate
PFIZER LABORATORIES DIV PFIZER INC
sildenafil citrate
Viatris Specialty LLC
sildenafil citrate
Viatris Specialty LLC
sildenafil citrate
Viatris Specialty LLC
Bryant Ranch Prepack
XLCARE Pharmaceuticals INC.
Exelan Pharmaceuticals, Inc.
Asclemed USA, Inc.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.